Concurrent Exercise Training
ConditionTyp 2 Diabetes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-60
SponsorPrince Sattam Bin Abdulaziz University
About this trial
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:
• Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.
Participants will:
* Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks * Visit the clinic before and after the 12-week experimental period for checkups and tests
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
men aged 40-60 years with a diagnosis of T2D
HbA1c levels between 7.0% and 9.0%
treatment with oral hypoglycemic agents for at least 6 months
a BMI <30 kg/m²
Disqualifiers
current insulin therapy
a cardiovascular event within the previous 6 months
cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training
body weight instability
Trial design
Design model
Parallel
Treatments tested in this trial
Exercise
BehavioralMorning concurrent high-intensity interval training and resistance training
exercise
Behavioralevening concurrent high-intensity interval training and resistance training between 16:00 and 19:00
Treatment groups
60 Participants
are divided into 3 treatment groupsGroup A: Morning concurrent training (amCT)Experimental treatment 1 intervention
Group B: Evening concurrent training (pmCT)Experimental treatment 1 intervention
Group C: The control group (CON)No intervention 0 interventions
Trial outcomes
Primary outcomes
1
glycemic control
HbA1c
Time frame
baseline and at 12 weeks.Secondary outcomes
1
lipid profile
total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides
Time frame
baseline and at 12 weeks2
cardiorespiratory fitness
VO2peak
Time frame
at baseline and at 12 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: